Valneva and Pfizer report antibody persistence data for lyme disease vaccine candidate
Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule
Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule
Subscribe To Our Newsletter & Stay Updated